The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 02, 2014
Filed:
Oct. 25, 2007
Applicants:
Shigeyuki Kon, Hokkaido, JP;
Chiemi Kimura, Hokkaido, JP;
Toshimitsu Uede, Hokkaido, JP;
Inventors:
Assignee:
Gene Techno Science Co., Ltd., Hokkaido, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/395 (2006.01); C12N 5/12 (2006.01); C12N 15/13 (2006.01); A61P 35/00 (2006.01); A61P 29/00 (2006.01); A61P 19/10 (2006.01); A61P 31/12 (2006.01); C07K 16/44 (2006.01); G01N 33/68 (2006.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); C07K 2317/565 (2013.01); C07K 2316/96 (2013.01); G01N 2800/108 (2013.01); G01N 2800/102 (2013.01); C07K 16/44 (2013.01); G01N 2800/26 (2013.01); G01N 33/6893 (2013.01); G01N 2800/24 (2013.01); G01N 2800/105 (2013.01); G01N 33/574 (2013.01); A61K 2039/505 (2013.01); C07K 2317/34 (2013.01);
Abstract
The present invention provides a monoclonal antibody which specifically recognizes RGD in the amino acid sequence of extracellular matrix proteins of a human and a mouse. By specifically inhibiting the RGD sequence-mediated adhesion, exertion of efficient effects on diseases such as inflammation, cancer, infectious disease, autoimmune diseases and osteoporosis and reduction in adverse effects can be expected at the same time. Therefore, better treatment methods can be provided to these diseases.